Hepatobiliary phase hypointensity on gadobenate dimeglumine-enhanced magnetic resonance imaging may improve the diagnosis of hepatocellular carcinoma

BACKGROUND: To determine the clinical value of hepatobiliary phase (HBP) hypointensity for noninvasive diagnosis of hepatocellular carcinoma (HCC). METHODS: A total of 246 high-risk patients with 263 selected nodules (126 HCCs, 137 non-HCCs) undergoing gadobenate dimeglumine (Gd-BOPTA)-enhanced magn...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yueming, Chen, Jianwei, Weng, Shuping, Yan, Chuan, Ye, Rongping, Zhu, Yuemin, Wen, Liting, Cao, Dairong, Hong, Jinsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859813/
https://www.ncbi.nlm.nih.gov/pubmed/33553348
http://dx.doi.org/10.21037/atm.2020.02.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859813/
https://www.ncbi.nlm.nih.gov/pubmed/33553348
http://dx.doi.org/10.21037/atm.2020.02.38

Ejemplares similares